TherapeuticsMD (TXMD) Assets Average (2011 - 2026)

TherapeuticsMD (TXMD) has reported Assets Average for 15 consecutive years, with $37.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 2.12% year-over-year to $37.6 million; the trailing twelve-month figure through Jun 2026 stood at $37.6 million (down 2.12% YoY), and the FY2025 full-year result was $38.2 million, down 6.88% from the prior year.
• Assets Average steadied at $37.6 million in Q2 2026 per TXMD's latest filing, from $37.6 million in the prior quarter.
• Across five years, Assets Average topped out at $151.4 million in Q1 2022 and bottomed at $37.6 million in Q2 2026.
• Historically, Assets Average has averaged $64.8 million across 5 years, with a median of $41.9 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Assets Average slumped 62.81% in 2023, then decreased 2.12% in 2026.
• Over 5 years, Assets Average stood at $112.2 million in 2022, then sank by 58.19% to $46.9 million in 2023, then declined by 16.45% to $39.2 million in 2024, then dropped by 2.61% to $38.2 million in 2025, then slipped by 1.59% to $37.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $37.6 million, $37.6 million, and $38.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.